| Pos |
No. |
Sex |
Age |
Organ |
Pathology diagnosis |
Grade |
Stage |
TNM |
Type † |
|
A1 |
1 |
M |
54 |
Esophagus |
Squamous cell carcinoma |
1 |
III |
T3N1M0 |
Malignant |
|
A2 |
2 |
M |
58 |
Esophagus |
Squamous cell carcinoma |
1 |
III |
T3N1M0 |
Malignant |
|
A3 |
3 |
F |
64 |
Esophagus |
Squamous cell carcinoma |
1–2 |
IV |
T2N1M1a |
Malignant |
|
A4 |
4 |
M |
43 |
Esophagus |
Squamous cell carcinoma with foreign-body giant cell reaction |
1 |
IIa |
T3N0M0 |
Malignant |
|
A5 |
5 |
M |
71 |
Esophagus |
Squamous cell carcinoma |
1 |
III |
T3N1M0 |
Malignant |
|
A6 |
6 |
F |
54 |
Esophagus |
Squamous cell carcinoma |
1 |
III |
T3N1M0 |
Malignant |
|
A7 |
7 |
F |
58 |
Esophagus |
Squamous cell carcinoma |
1 |
III |
T3N1M0 |
Malignant |
|
A8 |
8 |
M |
69 |
Esophagus |
Squamous cell carcinoma |
1 |
III |
T3N1M0 |
Malignant |
|
A9 |
9 |
M |
60 |
Esophagus |
Squamous cell carcinoma |
1 |
IIb |
T2N1M0 |
Malignant |
|
A10 |
10 |
F |
57 |
Esophagus |
Squamous cell carcinoma |
1 |
III |
T3N1M0 |
Malignant |
|
A11 |
11 |
M |
60 |
Esophagus |
Squamous cell carcinoma |
1 |
III |
T3N1M0 |
Malignant |
|
A12 |
12 |
M |
55 |
Esophagus |
Squamous cell carcinoma |
1 |
IIb |
T2N1M0 |
Malignant |
|
A13 |
13 |
F |
63 |
Esophagus |
Squamous cell carcinoma |
1 |
IIa |
T3N0M0 |
Malignant |
|
A14 |
14 |
M |
70 |
Esophagus |
Squamous cell carcinoma (fibrous connective tissue) |
– |
IIa |
T3N0M0 |
Malignant |
|
A15 |
15 |
F |
36 |
Esophagus |
Squamous cell carcinoma |
1 |
IIa |
T3N0M0 |
Malignant |
|
A16 |
16 |
M |
58 |
Esophagus |
Squamous cell carcinoma |
1 |
III |
T3N1M0 |
Malignant |
|
B1 |
17 |
M |
51 |
Esophagus |
Squamous cell carcinoma |
1 |
III |
T3N1M0 |
Malignant |
|
B2 |
18 |
M |
73 |
Esophagus |
Squamous cell carcinoma |
1 |
IIb |
T1N1M0 |
Malignant |
|
B3 |
19 |
M |
64 |
Esophagus |
Squamous cell carcinoma |
1 |
IIa |
T3N0M0 |
Malignant |
|
B4 |
20 |
M |
59 |
Esophagus |
Squamous cell carcinoma |
1 |
IIa |
T3N0M0 |
Malignant |
|
B5 |
21 |
F |
68 |
Esophagus |
Squamous cell carcinoma |
1 |
IIa |
T3N0M0 |
Malignant |
|
B6 |
22 |
M |
73 |
Esophagus |
Squamous cell carcinoma |
1 |
IIa |
T2N0M0 |
Malignant |
|
B7 |
23 |
M |
63 |
Esophagus |
Squamous cell carcinoma |
1 |
IIa |
T3N0M0 |
Malignant |
|
B8 |
24 |
M |
59 |
Esophagus |
Squamous cell carcinoma |
1 |
IIa |
T3N0M0 |
Malignant |
|
B9 |
25 |
M |
58 |
Esophagus |
Squamous cell carcinoma |
1 |
IIa |
T3N0M0 |
Malignant |
|
B10 |
26 |
M |
50 |
Esophagus |
Squamous cell carcinoma |
1 |
IIa |
T3N0M0 |
Malignant |
|
B11 |
27 |
F |
60 |
Esophagus |
Squamous cell carcinoma |
1 |
IIa |
T3N0M0 |
Malignant |
|
B12 |
28 |
M |
72 |
Esophagus |
Squamous cell carcinoma |
1 |
IIa |
T2N0M0 |
Malignant |
|
B13 |
29 |
M |
58 |
Esophagus |
Squamous cell carcinoma |
1 |
IIa |
T3N0M0 |
Malignant |
|
B14 |
30 |
M |
59 |
Esophagus |
Squamous cell carcinoma |
1 |
IIa |
T3N0M0 |
Malignant |
|
B15 |
31 |
M |
60 |
Esophagus |
Squamous cell carcinoma |
1 |
IIa |
T2N0M0 |
Malignant |
|
B16 |
32 |
M |
58 |
Esophagus |
Squamous cell carcinoma |
1 |
IIa |
T2N0M0 |
Malignant |
|
C1 |
33 |
M |
56 |
Esophagus |
Squamous cell carcinoma (sparse) with keratinization |
1 |
IIa |
T3N0M0 |
Malignant |
|
C2 |
34 |
M |
53 |
Esophagus |
Squamous cell carcinoma |
1 |
IIa |
T3N0M0 |
Malignant |
|
C3 |
35 |
M |
68 |
Esophagus |
Squamous cell carcinoma |
1 |
IIa |
T3N0M0 |
Malignant |
|
C4 |
36 |
F |
55 |
Esophagus |
Squamous cell carcinoma |
1 |
IIa |
T3N0M0 |
Malignant |
|
C5 |
37 |
M |
60 |
Esophagus |
Squamous cell carcinoma |
1 |
IIa |
T3N0M0 |
Malignant |
|
C6 |
38 |
F |
51 |
Esophagus |
Squamous cell carcinoma |
1 |
IIa |
T3N0M0 |
Malignant |
|
C7 |
39 |
M |
69 |
Esophagus |
Squamous cell carcinoma |
1 |
IIa |
T3N0M0 |
Malignant |
|
C8 |
40 |
M |
59 |
Esophagus |
Squamous cell carcinoma |
1 |
IIa |
T3N0M0 |
Malignant |
|
C9 |
41 |
M |
49 |
Esophagus |
Squamous cell carcinoma |
2 |
IIa |
T3N0M0 |
Malignant |
|
C10 |
42 |
M |
51 |
Esophagus |
Squamous cell carcinoma |
2 |
IIa |
T2N0M0 |
Malignant |
|
C11 |
43 |
M |
56 |
Esophagus |
Squamous cell carcinoma |
1–2 |
IIb |
T2N1M0 |
Malignant |
|
C12 |
44 |
M |
62 |
Esophagus |
Squamous cell carcinoma |
2 |
III |
T3N1M0 |
Malignant |
|
C13 |
45 |
F |
68 |
Esophagus |
Squamous cell carcinoma |
2 |
III |
T3N1M0 |
Malignant |
|
C14 |
46 |
M |
57 |
Esophagus |
Squamous cell carcinoma |
2 |
III |
T3N1M0 |
Malignant |
|
C15 |
47 |
M |
50 |
Esophagus |
Squamous cell carcinoma |
2 |
IIb |
T2N1M0 |
Malignant |
|
C16 |
48 |
F |
51 |
Esophagus |
Squamous cell carcinoma |
2 |
IIa |
T3N0M0 |
Malignant |
|
D1 |
49 |
M |
65 |
Esophagus |
Squamous cell carcinoma |
2 |
III |
T3N1M0 |
Malignant |
|
D2 |
50 |
M |
53 |
Esophagus |
Squamous cell carcinoma |
2 |
IIa |
T3N0M0 |
Malignant |
|
D3 |
51 |
M |
58 |
Esophagus |
Squamous cell carcinoma |
2 |
III |
T3N1M0 |
Malignant |
|
D4 |
52 |
F |
65 |
Esophagus |
Squamous cell carcinoma |
2 |
III |
T3N1M0 |
Malignant |
|
D5 |
53 |
F |
51 |
Esophagus |
Squamous cell carcinoma |
2 |
III |
T3N1M0 |
Malignant |
|
D6 |
54 |
M |
75 |
Esophagus |
Squamous cell carcinoma |
2 |
III |
T3N1M0 |
Malignant |
|
D7 |
55 |
M |
57 |
Esophagus |
Squamous cell carcinoma |
2 |
IIa |
T3N0M0 |
Malignant |
|
D8 |
56 |
M |
57 |
Esophagus |
Squamous cell carcinoma |
2 |
III |
T3N1M0 |
Malignant |
|
D9 |
57 |
M |
52 |
Esophagus |
Squamous cell carcinoma |
2 |
IIa |
T3N0M0 |
Malignant |
|
D10 |
58 |
M |
51 |
Esophagus |
Squamous cell carcinoma |
2 |
IIa |
T3N0M0 |
Malignant |
|
D11 |
59 |
F |
61 |
Esophagus |
Squamous cell carcinoma |
2 |
III |
T3N1M0 |
Malignant |
|
D12 |
60 |
M |
65 |
Esophagus |
Squamous cell carcinoma |
2 |
IIa |
T3N0M0 |
Malignant |
|
D13 |
61 |
F |
69 |
Esophagus |
Squamous cell carcinoma |
2 |
IIa |
T2N0M0 |
Malignant |
|
D14 |
62 |
F |
48 |
Esophagus |
Squamous cell carcinoma |
2 |
IIa |
T3N0M0 |
Malignant |
|
D15 |
63 |
M |
59 |
Esophagus |
Squamous cell carcinoma |
2 |
IIa |
T3N0M0 |
Malignant |
|
D16 |
64 |
F |
63 |
Esophagus |
Squamous cell carcinoma |
2 |
IIa |
T3N0M0 |
Malignant |
|
E1 |
65 |
F |
60 |
Esophagus |
Squamous cell carcinoma |
2 |
III |
T3N1M0 |
Malignant |
|
E2 |
66 |
M |
62 |
Esophagus |
Squamous cell carcinoma |
2 |
IIa |
T2N0M0 |
Malignant |
|
E3 |
67 |
F |
53 |
Esophagus |
Squamous cell carcinoma |
2 |
IIa |
T2N0M0 |
Malignant |
|
E4 |
68 |
M |
51 |
Esophagus |
Squamous cell carcinoma |
2 |
IIa |
T2N0M0 |
Malignant |
|
E5 |
69 |
F |
66 |
Esophagus |
Squamous cell carcinoma |
2 |
III |
T3N1M0 |
Malignant |
|
E6 |
70 |
M |
74 |
Esophagus |
Squamous cell carcinoma |
2 |
IIa |
T3N0M0 |
Malignant |
|
E7 |
71 |
M |
53 |
Esophagus |
Squamous cell carcinoma (smooth muscle) |
– |
IIa |
T3N0M0 |
Malignant |
|
E8 |
72 |
M |
61 |
Esophagus |
Squamous cell carcinoma |
1–2 |
IIa |
T3N0M0 |
Malignant |
|
E9 |
73 |
F |
64 |
Esophagus |
Squamous cell carcinoma |
2 |
III |
T3N1M0 |
Malignant |
|
E10 |
74 |
F |
52 |
Esophagus |
Squamous cell carcinoma |
2 |
IIa |
T2N0M0 |
Malignant |
|
E11 |
75 |
M |
67 |
Esophagus |
Squamous cell carcinoma |
2 |
III |
T3N1M0 |
Malignant |
|
E12 |
76 |
F |
64 |
Esophagus |
Squamous cell carcinoma |
2 |
III |
T3N1M0 |
Malignant |
|
E13 |
77 |
M |
54 |
Esophagus |
Squamous cell carcinoma |
2 |
III |
T3N1M0 |
Malignant |
|
E14 |
78 |
F |
65 |
Esophagus |
Squamous cell carcinoma |
2 |
III |
T3N1M0 |
Malignant |
|
E15 |
79 |
M |
51 |
Esophagus |
Squamous cell carcinoma (hyperplastic lymphatic tissue sparse) |
– |
III |
T3N1M0 |
Malignant |
|
E16 |
80 |
M |
50 |
Esophagus |
Squamous cell carcinoma |
2 |
IIb |
T2N1M0 |
Malignant |
|
F1 |
81 |
M |
56 |
Esophagus |
Squamous cell carcinoma |
2 |
I |
T1N0M0 |
Malignant |
|
F2 |
82 |
M |
44 |
Esophagus |
Squamous cell carcinoma |
2–3 |
IIa |
T3N0M0 |
Malignant |
|
F3 |
83 |
F |
70 |
Esophagus |
Squamous cell carcinoma |
3 |
IIa |
T2N0M0 |
Malignant |
|
F4 |
84 |
M |
71 |
Esophagus |
Squamous cell carcinoma |
3 |
IIb |
T2N1M0 |
Malignant |
|
F5 |
85 |
F |
64 |
Esophagus |
Squamous cell carcinoma |
2–3 |
III |
T3N1M0 |
Malignant |
|
F6 |
86 |
M |
53 |
Esophagus |
Squamous cell carcinoma |
3 |
III |
T3N1M0 |
Malignant |
|
F7 |
87 |
M |
53 |
Esophagus |
Squamous cell carcinoma |
3 |
IIb |
T2N1M0 |
Malignant |
|
F8 |
88 |
M |
49 |
Esophagus |
Squamous cell carcinoma |
3 |
IIa |
T2N0M0 |
Malignant |
|
F9 |
89 |
M |
50 |
Esophagus |
Squamous cell carcinoma |
3 |
IIa |
T3N0M0 |
Malignant |
|
F10 |
90 |
F |
48 |
Esophagus |
Squamous cell carcinoma |
2 |
IIa |
T3N0M0 |
Malignant |
|
F11 |
91 |
F |
38 |
Esophagus |
Squamous cell carcinoma |
2–3 |
III |
T3N1M0 |
Malignant |
|
F12 |
92 |
M |
64 |
Esophagus |
Squamous cell carcinoma |
2 |
IIa |
T3N0M0 |
Malignant |
|
F13 |
93 |
M |
50 |
Esophagus |
Squamous cell carcinoma |
3 |
IIa |
T3N0M0 |
Malignant |
|
F14 |
94 |
F |
60 |
Esophagus |
Squamous cell carcinoma |
3 |
IIa |
T3N0M0 |
Malignant |
|
F15 |
95 |
F |
53 |
Esophagus |
Squamous cell carcinoma |
3 |
IIa |
T3N0M0 |
Malignant |
|
F16 |
96 |
M |
70 |
Esophagus |
Squamous cell carcinoma |
3 |
III |
T3N1M0 |
Malignant |
|
G1 |
97 |
M |
45 |
Esophagus |
Squamous cell carcinoma |
3 |
IIa |
T3N0M0 |
Malignant |
|
G2 |
98 |
M |
63 |
Esophagus |
Squamous cell carcinoma (lymphatic tissue) |
– |
III |
T3N1M0 |
Malignant |
|
G3 |
99 |
M |
32 |
Esophagus |
Squamous cell carcinoma |
3 |
III |
T3N1M0 |
Malignant |
|
G4 |
100 |
M |
62 |
Esophagus |
Squamous cell carcinoma |
3 |
IIa |
T3N0M0 |
Malignant |
|
G5 |
101 |
F |
52 |
Esophagus |
Squamous cell carcinoma |
3 |
IIa |
T3N0M0 |
Malignant |
|
G6 |
102 |
F |
53 |
Esophagus |
Squamous cell carcinoma |
3 |
III |
T3N1M0 |
Malignant |
|
G7 |
103 |
M |
50 |
Esophagus |
Squamous cell carcinoma |
3 |
IIa |
T3N0M0 |
Malignant |
|
G8 |
104 |
M |
64 |
Esophagus |
Squamous cell carcinoma |
3 |
IIa |
T3N0M0 |
Malignant |
|
G9 |
105 |
F |
53 |
Esophagus |
Squamous cell carcinoma |
3 |
IIa |
T3N0M0 |
Malignant |
|
G10 |
106 |
F |
48 |
Esophagus |
Squamous cell carcinoma |
3 |
I |
T1N0M0 |
Malignant |
|
G11 |
107 |
M |
58 |
Esophagus |
Squamous cell carcinoma |
3 |
III |
T3N1M0 |
Malignant |
|
G12 |
108 |
M |
55 |
Esophagus |
Squamous cell carcinoma |
3 |
III |
T3N1M0 |
Malignant |
|
G13 |
109 |
M |
67 |
Esophagus |
Squamous cell carcinoma |
3 |
IIb |
T2N1M0 |
Malignant |
|
G14 |
110 |
M |
56 |
Esophagus |
Squamous cell carcinoma |
3 |
I |
T1N0M0 |
Malignant |
|
G15 |
111 |
M |
70 |
Esophagus |
Squamous cell carcinoma |
3 |
IIa |
T3N0M0 |
Malignant |
|
G16 |
112 |
F |
52 |
Esophagus |
Squamous cell carcinoma (sparse) |
3 |
IIa |
T3N0M0 |
Malignant |
|
H1 |
113 |
M |
56 |
Esophagus |
Squamous cell carcinoma |
2–3 |
IIa |
T2N0M0 |
Malignant |
|
H2 |
114 |
M |
55 |
Esophagus |
Squamous cell carcinoma |
3 |
IIa |
T3N0M0 |
Malignant |
|
H3 |
115 |
F |
59 |
Esophagus |
Squamous cell carcinoma |
3 |
IIb |
T2N1M0 |
Malignant |
|
H4 |
116 |
M |
51 |
Esophagus |
Squamous cell carcinoma |
3 |
IIa |
T3N0M0 |
Malignant |
|
H5 |
117 |
M |
52 |
Esophagus |
Squamous cell carcinoma |
3 |
I |
T1N0M0 |
Malignant |
|
H6 |
118 |
M |
53 |
Esophagus |
Squamous cell carcinoma |
3 |
IIa |
T2N0M0 |
Malignant |
|
H7 |
119 |
M |
62 |
Esophagus |
Squamous cell carcinoma |
3 |
IIa |
T2N0M0 |
Malignant |
|
H8 |
120 |
M |
53 |
Esophagus |
Squamous cell carcinoma |
3 |
IIa |
T2N0M0 |
Malignant |
|
H9 |
121 |
F |
54 |
Lymph node |
Metastatic squamous cell carcinoma of No. 06 |
1 |
– |
– |
Metastasis |
|
H10 |
122 |
M |
58 |
Lymph node |
Metastatic squamous cell carcinoma of No. 02 |
1 |
– |
– |
Metastasis |
|
H11 |
123 |
M |
69 |
Lymph node |
Metastatic squamous cell carcinoma of No. 08 |
1 |
– |
– |
Metastasis |
|
H12 |
124 |
M |
58 |
Lymph node |
Metastatic squamous cell carcinoma of No. 16 |
1 |
– |
– |
Metastasis |
|
H13 |
125 |
M |
54 |
Lymph node |
Metastatic squamous cell carcinoma of No. 01 |
1 |
– |
– |
Metastasis |
|
H14 |
126 |
F |
57 |
Lymph node |
Metastatic squamous cell carcinoma of No. 84 |
2 |
– |
– |
Metastasis |
|
H15 |
127 |
M |
71 |
Lymph node |
Metastatic squamous cell carcinoma (sparse) of No. 84 |
2 |
– |
– |
Metastasis |
|
H16 |
128 |
M |
53 |
Lymph node |
Metastatic squamous cell carcinoma of No. 50 |
1–2 |
– |
– |
Metastasis |
|
I1 |
129 |
M |
55 |
Lymph node |
Metastatic squamous cell carcinoma of No. 12 |
1–2 |
– |
– |
Metastasis |
|
I2 |
130 |
M |
58 |
Lymph node |
Metastatic squamous cell carcinoma (adipose tissue and blood vessel) of No. 51 |
– |
– |
– |
Metastasis |
|
I3 |
131 |
M |
73 |
Lymph node |
Metastatic squamous cell carcinoma of No. 18 |
2 |
– |
– |
Metastasis |
|
I4 |
132 |
F |
65 |
Lymph node |
Metastatic squamous cell carcinoma (sparse) of No. 52 |
1 |
– |
– |
Metastasis |
|
I5 |
133 |
M |
60 |
Lymph node |
Metastatic squamous cell carcinoma of No. 11 |
2 |
– |
– |
Metastasis |
|
I6 |
134 |
M |
50 |
Lymph node |
Metastatic squamous cell carcinoma of No. 47 |
1 |
– |
– |
Metastasis |
|
I7 |
135 |
F |
64 |
Lymph node |
Metastatic squamous cell carcinoma with necrosis of No. 03 |
1 |
– |
– |
Metastasis |
|
I8 |
136 |
M |
51 |
Lymph node |
Metastatic squamous cell carcinoma of No. 17 |
2 |
– |
– |
Metastasis |
|
I9 |
137 |
M |
60 |
Lymph node |
Metastatic squamous cell carcinoma (sparse) of No. 09 |
– |
– |
– |
Metastasis |
|
I10 |
138 |
M |
75 |
Lymph node |
Metastatic squamous cell carcinoma of No. 54 |
3 |
– |
– |
Metastasis |
|
I11 |
139 |
F |
68 |
Lymph node |
Metastatic squamous cell carcinoma of No. 45 |
2–3 |
– |
– |
Metastasis |
|
I12 |
140 |
M |
65 |
Lymph node |
Metastatic squamous cell carcinoma of No. 49 |
3 |
– |
– |
Metastasis |
|
I13 |
141 |
F |
65 |
Lymph node |
Metastatic squamous cell carcinoma (fibrofatty tissue) of No. 78 |
– |
– |
– |
Metastasis |
|
I14 |
142 |
F |
64 |
Lymph node |
Metastatic squamous cell carcinoma of No. 76 |
2 |
– |
– |
Metastasis |
|
I15 |
143 |
F |
64 |
Lymph node |
Metastatic squamous cell carcinoma of No. 85 |
2–3 |
– |
– |
Metastasis |
|
I16 |
144 |
F |
38 |
Lymph node |
Metastatic squamous cell carcinoma (cornification, necrosis and squamous cell carcinoma cell) of No. 91 |
– |
– |
– |
Metastasis |
|
J1 |
145 |
M |
53 |
Lymph node |
Metastatic squamous cell carcinoma of No. 86 |
2–3 |
– |
– |
Metastasis |
|
J2 |
146 |
M |
51 |
Lymph node |
Metastatic squamous cell carcinoma of No. 79 |
2 |
– |
– |
Metastasis |
|
J3 |
147 |
M |
67 |
Lymph node |
Metastatic squamous cell carcinoma with necrosis of No. 75 |
2 |
– |
– |
Metastasis |
|
J4 |
148 |
M |
50 |
Lymph node |
Metastatic squamous cell carcinoma of No. 80 |
3 |
– |
– |
Metastasis |
|
J5 |
149 |
F |
58 |
Lymph node |
Metastatic squamous cell carcinoma of No. 07 |
3 |
– |
– |
Metastasis |
|
J6 |
150 |
M |
62 |
Lymph node |
Metastatic squamous cell carcinoma of No. 44 |
3 |
– |
– |
Metastasis |
|
J7 |
151 |
M |
70 |
Lymph node |
Metastatic squamous cell carcinoma of No. 96 |
3 |
– |
– |
Metastasis |
|
J8 |
152 |
M |
32 |
Lymph node |
Metastatic squamous cell carcinoma of No. 99 |
3 |
– |
– |
Metastasis |
|
J9 |
153 |
F |
53 |
Lymph node |
Metastatic squamous cell carcinoma of No. 102 |
3 |
– |
– |
Metastasis |
|
J10 |
154 |
M |
53 |
Lymph node |
Metastatic squamous cell carcinoma of No. 87 |
3 |
– |
– |
Metastasis |
|
J11 |
155 |
F |
51 |
Lymph node |
Metastatic squamous cell carcinoma of No. 53 |
3 |
– |
– |
Metastasis |
|
J12 |
156 |
M |
54 |
Lymph node |
Metastatic squamous cell carcinoma of No. 77 |
3 |
– |
– |
Metastasis |
|
J13 |
157 |
M |
55 |
Lymph node |
Metastatic squamous cell carcinoma of No. 108 |
3 |
– |
– |
Metastasis |
|
J14 |
158 |
F |
59 |
Lymph node |
Metastatic squamous cell carcinoma of No. 115 |
3 |
– |
– |
Metastasis |
|
J15 |
159 |
M |
67 |
Lymph node |
Metastatic squamous cell carcinoma of No. 109 |
3 |
– |
– |
Metastasis |
|
J16 |
160 |
M |
71 |
Lymph node |
Metastatic squamous cell carcinoma of No. 05 |
3 |
– |
– |
Metastasis |
|
K1 |
161 |
F |
52 |
Esophagus |
Cancer adjacent tissue (esophagus tissue) of No. 101 |
– |
– |
– |
AT |
|
K2 |
162 |
M |
68 |
Esophagus |
Cancer adjacent tissue (reflux esophagitis) of No. 35 |
– |
– |
– |
AT |
|
K3 |
163 |
F |
63 |
Esophagus |
Cancer adjacent tissue (fibrofatty tissue) of No. 13 |
– |
– |
– |
AT |
|
K4 |
164 |
M |
59 |
Esophagus |
Cancer adjacent tissue (reflux esophagitis) of No. 30 |
– |
– |
– |
AT |
|
K5 |
165 |
M |
43 |
Esophagus |
Cancer adjacent tissue (chronic esophagitis) of No. 04 |
– |
– |
– |
AT |
|
K6 |
166 |
M |
69 |
Esophagus |
Cancer adjacent tissue (reflux esophagitis with epithelial proliferation) of No. 39 |
– |
– |
– |
AT |
|
K7 |
167 |
F |
51 |
Esophagus |
Cancer adjacent tissue (esophagus tissue) of No. 38 |
– |
– |
– |
AT |
|
K8 |
168 |
F |
60 |
Esophagus |
Cancer adjacent tissue (reflux esophagitis) of No. 27 |
– |
– |
– |
AT |
|
K9 |
169 |
M |
70 |
Esophagus |
Cancer adjacent tissue (reflux esophagitis) of No. 14 |
– |
– |
– |
AT |
|
K10 |
170 |
F |
68 |
Esophagus |
Cancer adjacent tissue (esophagus tissue) of No. 21 |
– |
– |
– |
AT |
|
K11 |
171 |
M |
60 |
Esophagus |
Cancer adjacent tissue (reflux esophagitis) of No. 37 |
– |
– |
– |
AT |
|
K12 |
172 |
M |
58 |
Esophagus |
Cancer adjacent tissue (chronic esophagitis with epithelial proliferation) of No. 25 |
– |
– |
– |
AT |
|
K13 |
173 |
F |
55 |
Esophagus |
Cancer adjacent tissue (chronic esophagitis) of No. 36 |
– |
– |
– |
AT |
|
K14 |
174 |
M |
63 |
Esophagus |
Cancer adjacent tissue (chronic esophagitis and local hyperplasia) of No. 23 |
– |
– |
– |
AT |
|
K15 |
175 |
M |
73 |
Esophagus |
Cancer adjacent tissue (esophagus tissue) of No. 22 |
– |
– |
– |
AT |
|
K16 |
176 |
M |
59 |
Esophagus |
Cancer adjacent tissue (chronic esophagitis) of No. 24 |
– |
– |
– |
AT |
|
L1 |
177 |
M |
58 |
Esophagus |
Cancer adjacent tissue (esophageal mucosa sparse and smooth muscle) of No. 29 |
– |
– |
– |
AT |
|
L2 |
178 |
M |
50 |
Esophagus |
Cancer adjacent tissue (chronic esophagitis with epithelial proliferation) of No. 89 |
– |
– |
– |
AT |
|
L3 |
179 |
M |
51 |
Esophagus |
Cancer adjacent tissue (reflux esophagitis with epithelial proliferation) of No. 58 |
– |
– |
– |
AT |
|
L4 |
180 |
F |
61 |
Esophagus |
Cancer adjacent tissue (chronic esophagitis) of No. 59 |
– |
– |
– |
AT |
|
L5 |
181 |
F |
69 |
Esophagus |
Cancer adjacent tissue (esophagus tissue) of No. 61 |
– |
– |
– |
AT |
|
L6 |
182 |
M |
62 |
Esophagus |
Cancer adjacent tissue (reflux esophagitis) of No. 100 |
– |
– |
– |
AT |
|
L7 |
183 |
M |
50 |
Esophagus |
Cancer adjacent tissue (chronic esophagitis with epithelial proliferation) of No. 103 |
– |
– |
– |
AT |
|
L8 |
184 |
M |
51 |
Esophagus |
Cancer adjacent tissue (esophagus tissue) of No. 68 |
– |
– |
– |
AT |
|
L9 |
185 |
F |
52 |
Esophagus |
Cancer adjacent tissue (esophagus tissue) of No. 112 |
– |
– |
– |
AT |
|
L10 |
186 |
M |
59 |
Esophagus |
Cancer adjacent tissue (esophagus tissue) of No. 63 |
– |
– |
– |
AT |
|
L11 |
187 |
F |
48 |
Esophagus |
Cancer adjacent tissue (fibrous connective tissue) of No. 62 |
– |
– |
– |
AT |
|
L12 |
188 |
F |
53 |
Esophagus |
Cancer adjacent tissue (smooth muscle) of No. 67 |
– |
– |
– |
AT |
|
L13 |
189 |
F |
48 |
Esophagus |
Cancer adjacent tissue (fibrous tissue and smooth mscle) of No. 90 |
– |
– |
– |
AT |
|
L14 |
190 |
M |
49 |
Esophagus |
Cancer adjacent tissue (esophageal mucosa) of No. 88 |
– |
– |
– |
AT |
|
L15 |
191 |
M |
58 |
Esophagus |
Cancer adjacent normal esophagus tissue (fibrous tissue and smooth muscle) of No. 29 |
– |
– |
– |
NAT |
|
L16 |
192 |
F |
48 |
Esophagus |
Cancer adjacent normal esophagus tissue (reflux esophagitis with epithelial proliferation) of No. 106 |
– |
– |
– |
NAT |
|
M1 |
193 |
M |
64 |
Esophagus |
Cancer adjacent normal esophagus tissue of No. 104 |
– |
– |
– |
NAT |
|
M2 |
194 |
M |
50 |
Esophagus |
Cancer adjacent normal esophagus tissue of No. 89 |
– |
– |
– |
NAT |
|
M3 |
195 |
F |
48 |
Esophagus |
Cancer adjacent normal esophageal mucosa tissue of No. 90 |
– |
– |
– |
NAT |
|
M4 |
196 |
M |
58 |
Esophagus |
Cancer adjacent normal esophagus tissue of No. 25 |
– |
– |
– |
NAT |
|
M5 |
197 |
F |
55 |
Esophagus |
Cancer adjacent normal esophagus tissue (chronic esophagitis with local epithelial proliferation) of No. 36 |
– |
– |
– |
NAT |
|
M6 |
198 |
M |
60 |
Esophagus |
Cancer adjacent normal esophagus tissue of No. 37 |
– |
– |
– |
NAT |
|
M7 |
199 |
F |
51 |
Esophagus |
Cancer adjacent normal esophagus tissue (chronic esophagitis with epithelial proliferation) of No. 38 |
– |
– |
– |
NAT |
|
M8 |
200 |
M |
69 |
Esophagus |
Cancer adjacent normal esophagus tissue of No. 39 |
– |
– |
– |
NAT |
**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum